Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association

Cardiovascular disease (CVD) is the leading global cause of death, accounting for 17.3 million deaths per year. Preventive treatment that reduces CVD by even a small percentage can substantially reduce, nationally and globally, the number of people who develop CVD and the costs of caring for them. This American Heart Association presidential advisory on dietary fats and CVD reviews and discusses the scientific evidence, including the most recent studies, on the effects of dietary saturated fat intake and its replacement by other types of fats and carbohydrates on CVD. In summary, randomized controlled trials that lowered intake of dietary saturated fat and replaced it with polyunsaturated vegetable oil reduced CVD by ≈30%, similar to the reduction achieved by statin treatment. Prospective observational studies in many populations showed that lower intake of saturated fat coupled with higher intake of polyunsaturated and monounsaturated fat is associated with lower rates of CVD and of other major causes of death and all-cause mortality. In contrast, replacement of saturated fat with mostly refined carbohydrates and sugars is not associated with lower rates of CVD and did not reduce CVD in clinical trials. Replacement of saturated with unsaturated fats lowers low-density lipoprotein cholesterol, a cause of atherosclerosis, linking biological evidence with incidence of CVD in populations and in clinical trials. Taking into consideration the totality of the scientific evidence, satisfying rigorous criteria for causality, we conclude strongly that lowering intake of saturated fat and replacing it with unsaturated fats, especially polyunsaturated fats, will lower the incidence of CVD. This recommended shift from saturated to unsaturated fats should occur simultaneously in an overall healthful dietary pattern such as DASH (Dietary Approaches to Stop Hypertension) or the Mediterranean diet as emphasized by the 2013 American Heart Association/American College of Cardiology lifestyle guidelines and the 2015 to 2020 Dietary Guidelines for Americans.

[1]  B. Bronte-Stewart,et al.  Effects of feeding different fats on serum-cholesterol level. , 1956, Lancet.

[2]  W. Insull,et al.  The influence of dietary fats on serum-lipid levels in man. , 1957, Lancet.

[3]  H. Malmros,et al.  The effect on serum-cholesterol of diets containing different fats. , 1957, Lancet.

[4]  W. Arnott The climate of medical education. , 1959, Lancet.

[5]  I. Browne,et al.  The management of the acute withdrawal phase in alcoholism. , 1959, Lancet.

[6]  C. Program Dietary fat and its relation to heart attacks and strokes. , 1961 .

[7]  E. Allen,et al.  Dietary fat and its relation to heart attacks and strokes. Report by the Central Committee for Medical and Community Program of the American Heart Association. , 1961, JAMA.

[8]  W. B. Thomson,et al.  Corn Oil in Treatment of Ischaemic Heart Disease , 1965, British medical journal.

[9]  C. Borchgrevink,et al.  Absence of prophylactic effect of linolenic acid in patients with coronary heart-disease. , 1966, Lancet.

[10]  J. N. Morris Controlled trial of soyabean oil in myocardial infarction. , 1968 .

[11]  P. Owren,et al.  A controlled trial of the effect of linolenic acid on incidence of coronary heart disease. The Norwegian vegetable oil experiment of 1965-66. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[12]  P. Allhoff,et al.  Controlled trial of soya-bean oil in myocardial infarction. , 1968, Lancet.

[13]  M. Rogers Historical Annotation: Sir John Scott Burdon‐Sanderson (1828‐1905) A Pioneer in Electrophysiology , 1969, Circulation.

[14]  U. Tomiyasu,et al.  A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of Atherosclerosis , 1969 .

[15]  P. Leren The Oslo Diet‐Heart Study: Eleven‐Year Report , 1970, Circulation.

[16]  M. Karvonen,et al.  Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. , 1972, Lancet.

[17]  H. Wisniewski,et al.  IMMUNOSUPPRESSION BY LINOLEIC ACID , 1975, The Lancet.

[18]  M. Karvonen,et al.  Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. , 1979, International journal of epidemiology.

[19]  H. Henkes,et al.  Favorable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy in adult onset diabetes mellitus. , 1981, Progress in lipid research.

[20]  M. Feinleib Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease , 1981 .

[21]  R. Wissler,et al.  Arterial lesions and blood lipids in rhesus monkeys fed human diets. , 1983, Experimental and molecular pathology.

[22]  M. Karvonen,et al.  Dietary prevention of coronary heart disease in women: the Finnish mental hospital study. , 1983, International journal of epidemiology.

[23]  A. Keys Serum cholesterol response to dietary cholesterol. , 1984, The American journal of clinical nutrition.

[24]  M. Singer,et al.  Nutritional Epidemiology , 2020, Definitions.

[25]  S. Srinivasan,et al.  Dietary Factors Relate to Cardiovascular Risk Factor in Early LIfe: Bogalusa Heart Study , 1988, Arteriosclerosis.

[26]  E. Vartiainen,et al.  Dietary changes in the North Karelia Project (1972-1982). , 1988, Preventive medicine.

[27]  L. Gatewood,et al.  Test of Effect of Lipid Lowering by Diet on Cardiovascular Risk: The Minnesota Coronary Survey , 1989, Arteriosclerosis.

[28]  P. Elwood,et al.  EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART) , 1989, The Lancet.

[29]  K. Gould,et al.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial , 1990, The Lancet.

[30]  Asb CAN LIFESTYLE CHANGES REVERSE CORONARY HEART DISEASE. , 1990 .

[31]  B. Lewis,et al.  Effects on Coronary Artery Disease of Lipid-Lowering Diet, or Diet Plus Cholestyramine, in the St. Thomasʼ Artherosclerosis Regression Study (STARS) , 1992 .

[32]  G. Watts,et al.  Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) , 1992, The Lancet.

[33]  T. Morgan,et al.  Dietary polyunsaturated fat decreases coronary artery atherosclerosis in a pediatric-aged population of African green monkeys. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[34]  W. Willett,et al.  Mediterranean diet pyramid: a cultural model for healthy eating. , 1995, The American journal of clinical nutrition.

[35]  J. Parks,et al.  Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[36]  R. Krauss,et al.  Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[37]  P. McLennan,et al.  Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats. , 1995, The Journal of nutrition.

[38]  J. Mann,et al.  Effects of coconut oil, butter, and safflower oil on lipids and lipoproteins in persons with moderately elevated cholesterol levels. , 1994, Journal of lipid research.

[39]  E. Vartiainen,et al.  Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk. , 1996, Preventive medicine.

[40]  R. Krauss,et al.  Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. , 1996, JAMA.

[41]  R. Krauss,et al.  A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. , 1996, JAMA.

[42]  M. Jauhiainen,et al.  Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects. , 1997, The American journal of clinical nutrition.

[43]  J. Strong,et al.  Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[44]  J. Sawyer,et al.  Hepatic origin of cholesteryl oleate in coronary artery atherosclerosis in African green monkeys. Enrichment by dietary monounsaturated fat. , 1997, The Journal of clinical investigation.

[45]  C. Hedrick,et al.  Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates. Role of cholesterol and fatty acids. , 1998, Progress in lipid research.

[46]  G. Billman,et al.  Prevention of Sudden Cardiac Death by Dietary Pure ω-3 Polyunsaturated Fatty Acids in Dogs , 1999 .

[47]  M. de Lorgeril,et al.  Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. , 1999, Circulation.

[48]  G. Billman,et al.  Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. , 1999, Circulation.

[49]  M A Waclawiw,et al.  Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study. , 1999, The Journal of pediatrics.

[50]  J. Viikari,et al.  Special Turku Coronary Risk Factor Intervention Project for Babies (STRIP). , 2000, The American journal of clinical nutrition.

[51]  V. Stevens,et al.  Efficacy and safety of lowering dietary intake of total fat, saturated fat, and cholesterol in children with elevated LDL cholesterol: the Dietary Intervention Study in Children. , 2000, The American journal of clinical nutrition.

[52]  J. Strong,et al.  Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[53]  B. McKnight,et al.  Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men. , 2000, The American journal of cardiology.

[54]  G. Bray,et al.  Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. , 2001, The American journal of clinical nutrition.

[55]  T. Raghunathan,et al.  Low density lipoprotein particle size and risk of early-onset myocardial infarction in women. , 2001, American journal of epidemiology.

[56]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. , 2001, The New England journal of medicine.

[57]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet , 2001 .

[58]  V. Stevens,et al.  Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). , 2001, Pediatrics.

[59]  F. Sacks,et al.  Low-density lipoprotein size, pravastatin treatment, and coronary events. , 2001, JAMA.

[60]  P. Ridker,et al.  Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women , 2002, Circulation.

[61]  S. Samman,et al.  Postprandial effects of dietary trans fatty acids on apolipoprotein(a) and cholesteryl ester transfer. , 2003, The American journal of clinical nutrition.

[62]  F. Sacks,et al.  Clinical review 163: Cardiovascular endocrinology: Low-density lipoprotein size and cardiovascular disease: a reappraisal. , 2003, The Journal of clinical endocrinology and metabolism.

[63]  T. Laitinen,et al.  Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. , 2003, JAMA.

[64]  Tina Costacou,et al.  Adherence to a Mediterranean diet and survival in a Greek population. , 2003, The New England journal of medicine.

[65]  R. Eckel,et al.  Dietary Hydrogenated Fat Increases High-Density Lipoprotein apoA-I Catabolism and Decreases Low-Density Lipoprotein apoB-100 Catabolism in Hypercholesterolemic Women , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[66]  A. Mathew,et al.  Diet and risk of ischemic heart disease in India. , 2005, The American journal of clinical nutrition.

[67]  C. Furberg,et al.  Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction? , 2006, The American journal of cardiology.

[68]  P. Barter,et al.  Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. , 2006, Journal of the American College of Cardiology.

[69]  R. Krauss,et al.  Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. , 2006, The American journal of clinical nutrition.

[70]  A. Gebre,et al.  Dietary polyunsaturated fat decreases interaction between low density lipoproteins and arterial proteoglycans , 1994, Lipids.

[71]  D. Mozaffarian,et al.  Trans fatty acids and cardiovascular disease. , 2006, The New England journal of medicine.

[72]  P. Kris-Etherton,et al.  Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. , 2007, The American journal of clinical nutrition.

[73]  J. Viikari,et al.  Impact of Repeated Dietary Counseling Between Infancy and 14 Years of Age on Dietary Intakes and Serum Lipids and Lipoproteins: The STRIP Study , 2007, Circulation.

[74]  Moyses Szklo,et al.  LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2007, Atherosclerosis.

[75]  J. Danesh,et al.  Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies , 2007, Circulation.

[76]  J. Viikari,et al.  Major dietary patterns and cardiovascular risk factors from childhood to adulthood. The Cardiovascular Risk in Young Finns Study , 2007, British Journal of Nutrition.

[77]  G. Schreiber,et al.  Dietary patterns in adolescence are related to adiposity in young adulthood in black and white females. , 2007, The Journal of nutrition.

[78]  W. J. Howard Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial , 2007 .

[79]  F. Hu,et al.  Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease. , 2007, The American journal of clinical nutrition.

[80]  A. Lichtenstein,et al.  Substitution of vegetable oil for a partially-hydrogenated fat favorably alters cardiovascular disease risk factors in moderately hypercholesterolemic postmenopausal women. , 2009, Atherosclerosis.

[81]  W. Willett,et al.  Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. , 2009, The American journal of clinical nutrition.

[82]  A. Keys,et al.  Prediction of Serum-Cholesterol Responses of Man to Changes in Fats in the Diet , 2009 .

[83]  D. Mozaffarian,et al.  Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils , 2009, European Journal of Clinical Nutrition.

[84]  J. Danesh,et al.  Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.

[85]  Samia Mora,et al.  Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women , 2009, Circulation.

[86]  J. Geleijnse,et al.  n-3 fatty acids and cardiovascular events after myocardial infarction. , 2010, The New England journal of medicine.

[87]  D. Mozaffarian,et al.  Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010, PLoS medicine.

[88]  R. Krauss,et al.  Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet , 2010, Journal of Lipid Research.

[89]  F. Hu,et al.  Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. , 2010, The American journal of clinical nutrition.

[90]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[91]  G. Moneta,et al.  Major Lipids, Apolipoproteins, and Risk of Vascular Disease , 2010 .

[92]  A. Astrup,et al.  Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies , 2011, European Journal of Clinical Nutrition.

[93]  V. Lee,et al.  Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. , 2011, The American journal of clinical nutrition.

[94]  W. Willett,et al.  The global availability of n-3 fatty acids , 2011, Public Health Nutrition.

[95]  T. Marshall,et al.  Dietary Guidelines for Americans, 2010: an update. , 2011, Journal of the American Dental Association.

[96]  R. Krauss,et al.  Changes in atherogenic dyslipidemia induced by carbohydrate restriction in men are dependent on dietary protein source. , 2011, The Journal of nutrition.

[97]  Moshe Levi,et al.  Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. , 2011, Circulation.

[98]  William Weintraub,et al.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. , 2011, The New England journal of medicine.

[99]  John Spertus,et al.  Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study , 2012, The Lancet.

[100]  Zahi A Fayad,et al.  Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. , 2012, Circulation.

[101]  R. Collins,et al.  Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study , 2012, Circulation.

[102]  Markus Abt,et al.  Effects of dalcetrapib in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[103]  An Pan,et al.  α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. , 2012, The American journal of clinical nutrition.

[104]  M. Szklo,et al.  The Multi-Ethnic Study of Atherosclerosis (MESA) , 2012 .

[105]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. , 2012, Lancet.

[106]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012, The Lancet.

[107]  J. Sawyer,et al.  LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis[S] , 2013, Journal of Lipid Research.

[108]  S. Leeder,et al.  The effectiveness of policies for reducing dietary trans fat: a systematic review of the evidence. , 2013, Bulletin of the World Health Organization.

[109]  John M Davis,et al.  Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis , 2013, BMJ : British Medical Journal.

[110]  M. Katan,et al.  Trans fatty acids and cardiovascular health: research completed? , 2013, European Journal of Clinical Nutrition.

[111]  D. Mozaffarian,et al.  Biomarkers of Dairy Fatty Acids and Risk of Cardiovascular Disease in the Multi‐Ethnic Study of Atherosclerosis , 2013, Journal of the American Heart Association.

[112]  Dolores Corella,et al.  Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013, The New England journal of medicine.

[113]  W. Willett,et al.  Dietary Linoleic Acid and Risk of Coronary Heart Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies , 2014, Circulation.

[114]  A. Lichtenstein Dietary Trans Fatty Acids and Cardiovascular Disease Risk: Past and Present , 2014, Current Atherosclerosis Reports.

[115]  D. Mozaffarian,et al.  Plasma Phospholipid Trans‐Fatty Acids Levels, Cardiovascular Diseases, and Total Mortality: The Cardiovascular Health Study , 2014, Journal of the American Heart Association.

[116]  M. Katan,et al.  Association of dietary, circulating, and supplement fatty acids with coronary risk. , 2014, Annals of internal medicine.

[117]  He Zhang,et al.  Loss-of-function mutations in APOC3, triglycerides, and coronary disease. , 2014, The New England journal of medicine.

[118]  Alex P. Reiner,et al.  Loss-of-Function Mutations in APOC 3 , Triglycerides , and Coronary Disease , 2014 .

[119]  Janusz Wnek,et al.  2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[120]  Simon G Thompson,et al.  Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. , 2014, Annals of internal medicine.

[121]  L. Appel,et al.  Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial. , 2014, JAMA.

[122]  A. B. Hill,et al.  "The Environment and Disease: Association or Causation?" (1965), by Austin Bradford Hill , 2017 .

[123]  R. Krauss,et al.  Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial. , 2015, The American journal of clinical nutrition.

[124]  J. Mckenney,et al.  National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report. , 2015, Journal of clinical lipidology.

[125]  F. Sacks,et al.  The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis. , 2015, Journal of clinical lipidology.

[126]  Improve-It Investigators Ezetimibe added to statin therapy after acute coronary syndromes , 2015 .

[127]  M. Lindholm,et al.  Altered metabolism of LDL in the arterial wall precedes atherosclerosis regression. , 2015, Circulation research.

[128]  Joseph Beyene,et al.  Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies , 2015, BMJ : British Medical Journal.

[129]  Ira Tabas,et al.  Recent insights into the cellular biology of atherosclerosis , 2015, The Journal of cell biology.

[130]  H. Ginsberg,et al.  PCSK9 inhibitors and cardiovascular disease: heralding a new therapeutic era , 2015, Current opinion in lipidology.

[131]  S. Stender In equal amounts, the major ruminant trans fatty acid is as bad for LDL cholesterol as industrially produced trans fatty acids, but the latter are easier to remove from foods. , 2015, The American journal of clinical nutrition.

[132]  A. Astrup,et al.  Diets with high-fat cheese, high-fat meat, or carbohydrate on cardiovascular risk markers in overweight postmenopausal women: a randomized crossover trial. , 2015, The American journal of clinical nutrition.

[133]  Alex P. Reiner,et al.  Mendelian randomization of blood lipids for coronary heart disease , 2014, European heart journal.

[134]  E. Fisher,et al.  How an artery heals. , 2015, Circulation research.

[135]  Matthew K Ito,et al.  The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association. , 2015, Circulation.

[136]  P. Kris-Etherton,et al.  High-oleic canola oil consumption enriches LDL particle cholesteryl oleate content and reduces LDL proteoglycan binding in humans. , 2015, Atherosclerosis.

[137]  L. Hooper,et al.  Reduction in saturated fat intake for cardiovascular disease. , 2015, The Cochrane database of systematic reviews.

[138]  E. Rimm,et al.  Saturated Fats Compared With Unsaturated Fats and Sources of Carbohydrates in Relation to Risk of Coronary Heart Disease: A Prospective Cohort Study. , 2015, Journal of the American College of Cardiology.

[139]  John M. Davis,et al.  Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73) , 2016, British Medical Journal.

[140]  M. Eyres,et al.  Coconut oil consumption and cardiovascular risk factors in humans. , 2016, Nutrition reviews.

[141]  J. Manson,et al.  Association of Specific Dietary Fats With Total and Cause-Specific Mortality. , 2016, JAMA internal medicine.

[142]  D. Mozaffarian,et al.  ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. , 2016, JAMA internal medicine.

[143]  J. Manson,et al.  Dairy fat and risk of cardiovascular disease in 3 cohorts of US adults. , 2016, The American journal of clinical nutrition.

[144]  Dajiang J. Liu,et al.  Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease , 2016, Science.

[145]  D. Mozaffarian,et al.  Dietary Intake Among US Adults, 1999-2012. , 2016, JAMA.

[146]  K. Kelley,et al.  Corn oil intake favorably impacts lipoprotein cholesterol, apolipoprotein and lipoprotein particle levels compared with extra-virgin olive oil , 2017, European Journal of Clinical Nutrition.

[147]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.